Gene · 977
Papers2,195
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,195
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes? | J Exp Clin Cancer Res | 2022 | 36114508 | PubTator, text mining | PubMed |
| Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle. | Oncogenesis | 2022 | 36109501 | PubTator, text mining | PubMed |
| An innovative strategy to identify new targets for delivering antibodies to the brain has led to the exploration of the integrin family. | PLoS One | 2022 | 36108060 | PubTator, text mining | PubMed |
| Antimicrobial Effects of Tetraspanins: A New Turnabout in Treatment of Microorganisms. | Malays J Med Sci | 2022 | 36101528 | PubTator, text mining | PubMed |
| Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction. | Int J Mol Sci | 2022 | 36077137 | PubTator, text mining | PubMed |
| Short histological kaleidoscope - recent findings in histology. Part I. | Rom J Morphol Embryol | 2022 | 36074664 | PubTator, text mining | PubMed |
| Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights. | Front Pharmacol | 2022 | 36071839 | PubTator, text mining | PubMed |
| The putative mechanistic insights on how SARS-CoV-2 might influence the outcomes in cancer patients. | Exp Hematol Oncol | 2022 | 36071512 | PubTator, text mining | PubMed |
| Integrin α3 negative podocytes: A gene expression study. | Matrix Biol Plus | 2022 | 36060790 | PubTator, text mining | PubMed |
| Methamphetamine induces transcriptional changes in cultured HIV-infected mature monocytes that may contribute to HIV neuropathogenesis. | Front Immunol | 2022 | 36059515 | PubTator, text mining | PubMed |
| Alternating exosomes and their mimetics as an emergent strategy for targeted cancer therapy. | Front Mol Biosci | 2022 | 36032679 | PubTator, text mining | PubMed |
| Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders. | Front Immunol | 2022 | 36032160 | PubTator, text mining | PubMed |
| Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment. | Cancer Sci | 2022 | 36028467 | PubTator, text mining | PubMed |
| New Insights into Renal Failure in a Cohort of 317 Patients with Autosomal Dominant Forms of Alport Syndrome: Report of Two Novel Heterozygous Mutations in COL4A3. | J Clin Med | 2022 | 36013122 | PubTator, text mining | PubMed |
| Dynamin-Independent Mechanisms of Endocytosis and Receptor Trafficking. | Cells | 2022 | 36010634 | PubTator, text mining | PubMed |
| Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors. | Cells | 2022 | 36010583 | PubTator, text mining | PubMed |
| [Research Progress on the Application of Liquid Biopsy in the Diagnosis and Treatment of Small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2022 | 36002198 | PubTator, text mining | PubMed |
| The role of tetraspanins pan-cancer. | iScience | 2022 | 35992081 | PubTator, text mining | PubMed |
| Exosome-based strategies for diagnosis and therapy of glioma cancer. | Cancer Cell Int | 2022 | 35989351 | PubTator, text mining | PubMed |
| RSPO2 defines a distinct undifferentiated progenitor in the tendon/ligament and suppresses ectopic ossification. | Sci Adv | 2022 | 35984875 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/977/papers?page=19